by means of a case-control study we investigated the association between hla phenotypes and the development of proteinuria after aurothioglucose or d-penicillamine treatment in patients with rheumatoid arthritis ( ra ) .
C0018033
aurothioglucose
C0003873
rheumatoid arthritis